Hilleman CEO Moving On, Hands Baton To Ex-Takeda Executive

Hilleman CEO Davinder Gill is leaving the global vaccine R&D organization after eight years at the helm and several mileposts. Incoming CEO Raman Rao takes charge from 1 February.

Team_Structure_Cubes
Leadership Change At Hilleman • Source: Shutterstock

Hilleman Laboratories’ long-serving CEO, Davinder Gill, is moving on after an eventful stint at the helm and will hand over the reins to former Takeda Pharmaceutical Co. Ltd. executive Raman Rao.

Gill, who has been Hilleman’s CEO since 2012, has steered the global vaccine R&D organization to some important milestones including...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip